MSB 2.89% $1.25 mesoblast limited

FDA does not over-rule positive ODAC decisions, page-68

  1. 607 Posts.
    lightbulb Created with Sketch. 168
    Fait acompli? I don't think anyone could say that with a start face... We all THINK based on different factors that it will get approved. BUT if everytime I thought something was going to happen actually happens I wouldn't be here....

    so what the FDA thinks is all that matters, and they have not approved it yet. That's the fact the market is pricing. If it does finally get approval, then there will be fireworks... from those that were hesitant to get in before actual approval, to those that were betting against approval (them shorters) and to those that were simply waiting for confirmation that the FDA is finally open to cellulure medicine ... That's a lot of money and buying that will need to find its way in and up against those who will no doubt now think they have a pathway to an even bigger payday in the form of covid treatment and the other phase 3s

    so the answer is no way is it factored in, not even close, strap yourself in for either a rocket ride or slippery slide.

    glta. As always dyor.

    in God we trust.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.